| 1 |
Asaka, O. and M. Shoda. 1996. Biocontrol of Rizoctonia solani damping-off of tomato with Bacillus subtilis RB14. Appl. Environ. Microbiol. 62, 4081-4085
PUBMED
ScienceOn
|
| 2 |
Besson, F., C. Chevanet, and G. Michel. 1987. Influence of the culture medium on the production of iturin A by Bacillus subtilis. J. Gen. Microbiol. 133, 767-772
DOI
PUBMED
ScienceOn
|
| 3 |
Besson, F. and G. Michel. 1987. Isolation and characterization of new iturins: iturin D and iturin E. J. Antibiot. 40, 437-442
DOI
PUBMED
|
| 4 |
Besson, F. and G. Michel. 1991. Influence of divalent ions on the solubility of iturin and bacillomycin L, antifungal peptidolipids of Bacillus subtilis. Microbios 65, 15-21
PUBMED
ScienceOn
|
| 5 |
Chung, Y.R., C.H. Kim, I.H. Hwang, and J.S. Chun. 2000. Paenibacillus koreensis sp. nov., a new species that produces an iturinlike antifungal compound. Int. J. Syst. Evol. Microb. 50, 1495-1500
DOI
ScienceOn
|
| 6 |
Maget-Dana, R., F. Heitz, M. Ptak, F. Peypoux, and M. Guinand. 1985. Bacterial lipopeptides induce ion-conducting pores in planar bilayers. Biochem. Biophy. Res. Comm. 129, 965-971
DOI
ScienceOn
|
| 7 |
Maget-Dana, R., M. Ptak, F. Peypoux, and G. Michel. 1985. Poreforming properties of iturin A, a lipopeptide antibiotic. Biochem. Biophy. Acta. 815, 405-409
DOI
ScienceOn
|
| 8 |
Martirani, L., M. Varcamonti, G. Naclerio, and M. De Felice. 2002. Purification and partial characterization of bacillocin 490, a novel bacteriocin produced by a thermophilic strain of Bacillus licheniformis. Microb. Cell Fact. 1, 1-5
DOI
PUBMED
ScienceOn
|
| 9 |
Mizumoto, S., M. Hirai, and M. Shoda. 2006. Production of lipopeptide antibiotic iturin A using soybean curd residue cultivated with Bacillus subtilis in solid-state fermentation. Appl. Microbiol. Biotechnol. 72, 869-875
DOI
ScienceOn
|
| 10 |
Peypoux, F., J.M. Bonmatin, and J. Wallach. 1999. Recent trends in the biochemistry of surfactin. Appl. Microbiol. Biotechnol. 51, 553-563
DOI
ScienceOn
|
| 11 |
Stein, T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol. 56, 845-857
DOI
PUBMED
ScienceOn
|
| 12 |
Toure, Y., M. Ongena, P. Jacques, A. Guiro, and P. Thonart. 2004. Role of lipopeptides produced by Bacillus subtilis GA1 in the reduction of grey mould disease caused by Botrytis cinerea on apple. J. Appl. Microbiol. 96, 1151-1160
DOI
ScienceOn
|
| 13 |
Walton. R.B. and H.B. Woodruff. 1949. A crystalline antifungal agent, mycosubtilin, isolated from subtilin broth. J. Clin. Invest. 28, 924-926
DOI
PUBMED
ScienceOn
|
| 14 |
Rahman, M.S., T. Ano, and M. Shoda. 2006. Second stage production of iturin A by induced germination of Bacillus subtilis RB14. J. Biotechnol. 125, 513-515
DOI
ScienceOn
|
| 15 |
Maget-Dana, R. and F. Peypoux. 1994. Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties. Toxicology 87, 151-174
DOI
PUBMED
ScienceOn
|
| 16 |
Mizumoto, S., M. Hirai, and M. Shoda. 2007. Enhanced iturin A production by Bacillus subtilis and its effect on suppression of the plant pathogen Rhizoctonia solani. Appl. Microbiol. Biotechnol. 75, 1267-1274
DOI
ScienceOn
|
| 17 |
Latoud, C., F. Peypoux, and G. Michel. 1990. Interaction of iturin A, a lipopeptide antibiotic, with Saccharomyces cerevisiae cells: influence of the sterol membrane composition. Can. J. Microbiol. 36, 384-389
DOI
ScienceOn
|
| 18 |
Klich, M.A., K.S. Arthur, A.R. Lax, and J.M. Bland. 1994. Iturin A: a potential new fungicide for stored grains. Mycopathologia 127, 123-127
DOI
ScienceOn
|
| 19 |
Eshita, S.M. and N.H. Roberto. 1995. Bacillomycin  , a new antibiotic of the iturin group: isolations, structures, and antifungal activities of the congeners. J. Antibiot. 48, 1240-1247
DOI
PUBMED
|
| 20 |
Kim, P.I., H. Bai, D. Bai, H. Chae, S. Chung, Y. Kim, R. Park, and Y.T. Chi. 2004. Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26. J. Appl. Microbiol. 97, 942-949
DOI
ScienceOn
|
| 21 |
Akpa, E., P. Jacques, B. Wathelet, M. Paquot, R. Fuchs, H. Budzikiewicz, and P. Thonart. 2001. Influence of culture conditions on lipopeptide production by Bacillus subtilis. Appl. Biochem. Biotechnol. 91-93, 551-561
DOI
ScienceOn
|
| 22 |
Romero, D., A. de Vincente, R.H. Rakotoaly, S.E. Dufour, J.W. Veening, E. Arrebola, F.M. Cazorla, O. Kuipers, M. Paquot, and A. Perez-Garcia. 2007. The iturin and fengycin families of lipopeptides are key factors in antagonism of Bacillus subtilis toward Podosphaera fusca. Mol. Plant-Microbe Interact. 20, 430-440
DOI
ScienceOn
|
| 23 |
Bizani, D., A.S. Motta, J.A.C. Morrissy, R.M.S. Terra, A.A. Souto, and A. Brandelli. 2005. Antibacterial activity of cerein 8A, a bacteriocin-like peptide produced by Bacillus cereus. Int. Microbiol. 8, 125-131
PUBMED
|
| 24 |
Mizumoto, S. and M. Shoda. 2007. Medium optimization of antifungal lipopeptide, iturin A, production by Bacillus subtilis in solid-state fermentation by response surface methodology. Appl. Microbiol. Biotechnol. 76, 101-108
DOI
ScienceOn
|
| 25 |
Sieber, S.A. and M.A. Marahiel. 2003. Learning from nature's drug factories: nonribosomal synthesis of macrocyclic peptides. J. Bacteriol. 185, 7036-7043
DOI
ScienceOn
|
| 26 |
Kondoh, M., M. Hirai, and M. Shoda. 2001. Integrated biological and chemical control of damping-off caused by Rhizoctonia solani using Bacillus subtilis RB14-C and flutolanil. J. Biosci. Bioeng. 91, 173-177
DOI
ScienceOn
|
| 27 |
Landy, M., G.H. Warren, S.B. Rosenman, and L.G. Colio. 1948. Bacillomycin: an antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. Exp. Biol. Med. 67, 539-541
DOI
PUBMED
|
| 28 |
Katz, E. and A.L. Demain. 1977. The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriol. Rev. 41, 449-474
PUBMED
ScienceOn
|
| 29 |
Cho, S.J., S.K. Lee, B.J. Cha, Y.H. Kim, and K.S. Shin, 2003. Detection and characterization of the Gloeosporium gloeosporioides growth inhibitory compound iturin A from Bacillus subtilis strain KS03. FEMS Microbiol. Lett. 223, 47-51
DOI
ScienceOn
|
| 30 |
Klich, M.A., A.R. Lax, and J.M. Bland. 1991. Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis. Mycopathologia 116, 77-80
DOI
ScienceOn
|
| 31 |
Hsieh, F.C., T.C. Lin, M. Meng, and S.S. Kao. 2008. Comparing methods for identifying Bacillus strains capable of producing the antifungal lipopeptide iturin A. Curr. Microbiol. 56, 1-5
DOI
ScienceOn
|
| 32 |
Marahiel, M.A., M.M. Nakano, and P. Zuber. 1993. Regulation of peptide antibiotic production in Bacillus. Mol. Microbiol. 7, 631-636
DOI
ScienceOn
|
| 33 |
Han, J.S., J.H. Cheng, T.M. Yoon, J. Song, A. Rajkarnikar, W.G. Kim, I.D. Yoo, and Y.Y. Yang. 2006. Biological control agent of common scab disease by antagonistic strain Bacillus sp. sunhua. J. Appl. Microbiol. 99, 213-221
DOI
ScienceOn
|
| 34 |
Kleerebezem, M., L.E.N. Quadri, O.P. Kuipers, and W.M. de Vos. 1997. Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-negative bacteria. Mol. Microbiol. 24, 895-904
DOI
ScienceOn
|
| 35 |
Kolter, R. 1992. Genetics of ribosomally synthesized peptide antibiotics. Ann. Rev. Microbiol. 46, 141-163
DOI
ScienceOn
|
| 36 |
Kajimura, Y., M. Sugiyama, and M. Kaneda. 1995. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2. J. Antibiot. 48, 1095-1103
DOI
PUBMED
|
| 37 |
Phister, T.G., D.J. O'Sullivan, and L.L. Mckay. 2004. Identification of bacilysin, Chlorotetaine, and iturin A produced by Bacillus sp. strain CS93 isolated from pozol, a Mexican fermented maize dough. Appl. Environ. Microbiol. 70, 631-634
DOI
ScienceOn
|
| 38 |
Citernesi, A.S., C. Filippi, G. Bagnoli, and M. Giovannetti. 1994. Effects of the antimycotic molecule iturin A2, secreted by Bacillus subtilis strain M51, on arbuscular mycorrhizal fungi. Microbiol. Res. 149, 241-246
DOI
PUBMED
ScienceOn
|
| 39 |
Besson, F., F. Peypoux, and G. Michel. 1979. Antifungal activity upon Saccharomyces cerevisiae of iturin A, mycosubtilin, bacillomycin L and of their derivatives; inhibition of this antifungal activity by lipid antagonists. J. Antibiot. 32, 828-833
DOI
PUBMED
|
| 40 |
Burianek, L.L. and A.E. Yousef. 2000. Solvent extraction of bacteriocins from liquid cultures. Lett. Appl. Microbiol. 31, 193-197
DOI
ScienceOn
|
| 41 |
Moyne, A.L., R. Shelby, T.E. Cleveland, and S. Tuzun. 2001. Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus. J. Appl. Microbiol. 90, 622-629
DOI
ScienceOn
|
| 42 |
Teo, A.Y.L. and H.M. Tan. 2005. Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens. Appl. Environ. Microbiol. 71, 4185-4190
DOI
ScienceOn
|
| 43 |
Peypoux, F., F. Besson, G. Michel, and L. Delcambe. 1979. Preparation and antibacterial activity upon Micrococcus luteus of derivatives of iturin A, mycosubtilin, and bacillomycin L. antibiotics from Bacillus subtilis. J. Antibiot. 32, 136-140
DOI
PUBMED
|
| 44 |
Besson, F. and G. Michel. 1988. Bacillomycins  and  : isolation and characterization. J. Antibiot. 41, 282-288
DOI
PUBMED
|
| 45 |
Kim, S.I., J.Y. Chang, I.C. Kim, and H.C. Chang. 2001. Characterization of bacteriocin from Bacillus subtilis cx1. Kor. J. Appl. Microbiol. Biotechnol. 29, 50-55
과학기술학회마을
|
webmaster
